Company performance
Current Price
as of Jan 10, 2025$0.62
P/E Ratio
N/A
Market Cap
$17.83M
Description
Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.
Metrics
Overview
- HQGainesville, FL
- SectorHealth Technology
- IndustryBiotechnology
- TickerCYTH
- Price$0.623-9.71%
Trading Information
- Market cap$17.83M
- Float57.37%
- Average Daily Volume (1m)61,814
- Average Daily Volume (3m)35,576
- EPS-$0.90
Company
- Revenue$0.87M
- Rev growth (1yr)-52.82%
- Net income-$8.83M
- Gross margin-268.79%
- EBITDA margin-3,545.02%
- EBITDA-$8.29M
- EV$33.94M
- EV/Revenue38.98
- P/EN/A
- P/S20.56
- P/BN/A
Documents
SEC Filings
Factset Street Account
Factset